Eltrombopag for the treatment of children with persistent and chronic immune thrombocytopenia (PETIT): a randomised, multicentre, placebo-controlled study (vol 2, pg 315, 2015)

被引：0
|
作者：
Bussel, James B.
de Miguel, Purificacion Garcia
Despotovic, Jenny M.
机构：
来源：
LANCET HAEMATOLOGY | 2015年 / 2卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E407 / E407
页数：1
相关论文
共 50 条
  • [31] A Multicentre, Double Blind, Randomised, Placebo-Controlled, Cross Over Study of Levetiracetam in the Prophylaxis of "Chronic Daily Headache"
    Beran, Roy
    Spira, Paul
    NEUROLOGY, 2009, 73 (04) : 332 - 332
  • [32] Therapy of chronic Epicondylopathia humeri radialis with botulinumtoxin A - a double-blind, placebo-controlled and randomised multicentre study
    Placzek, R
    Deuretzbacher, G
    Meiss, LA
    ZEITSCHRIFT FUR ORTHOPADIE UND IHRE GRENZGEBIETE, 2005, 143 (05): : 498 - 503
  • [33] ROMIPLOSTIM IN CHILDREN WITH IMMUNE THROMBOCYTOPENIA: A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY
    Tarantino, M.
    Bussel, J.
    Blanchette, V.
    Despotovic, J.
    Bennett, C.
    Raj, A.
    Williams, B.
    Beam, D.
    Morales, J.
    Rose, M.
    Carpenter, N.
    Eisen, M.
    HAEMATOLOGICA, 2016, 101 : 137 - 137
  • [34] Metformin in women with type 2 diabetes in pregnancy (MiTy): a multicentre, international, randomised, placebo-controlled trial (vol 8, pg 834, 2020)
    Feig, D. S.
    Donovan, L. E.
    Zinman, B.
    LANCET DIABETES & ENDOCRINOLOGY, 2020, 8 (11): : E6 - E6
  • [35] Rituximab As Second Line Treatment For Adult Immune Thrombocytopenia (ITP): A Multicentre, Randomized, Double Blind, Placebo-Controlled Study - The Ritp Study (NCT00344149)
    Ghanima, Waleed
    Khelif, Abderrahim
    Benromdhan, Neila
    Waage, Anders
    Tjonnfjord, Geir E.
    Michel, Marc
    Bernadette, Dame
    Kahrs, Johannes
    Holme, Pal Andre
    BLOOD, 2013, 122 (21)
  • [36] Effects of liraglutide in the treatment of obesity: a randomised, double-blind, placebo-controlled study (vol 374, pg 1606, 2009)
    Astrup, A.
    Roessner, S.
    Van Gaal, L.
    LANCET, 2010, 375 (9719): : 984 - 984
  • [37] Regular, sustained-release morphine for chronic breathlessness: a multicentre, double-blind, randomised, placebo-controlled trial (vol 75, pg 50, 2020)
    Currow, D.
    Louw, S.
    McCloud, P.
    THORAX, 2020, 75 (07) : E5 - E5
  • [38] Intravenous immune globulin (10% caprylate-chromatography purified) for the treatment of chronic inflammatory demyelinating polyradiculoneuropathy (ICE study): a randomised placebo-controlled trial (vol 7, pg 136, 20008)
    Hughes, R. A. C.
    Donofrio, P.
    Bril, V
    Bourgin, P.
    Zeitzer, J. M.
    Mignot, E.
    Chin, R. F. M.
    Neville, B. G. R.
    Peckham, C.
    Wade, A.
    Bedford, H.
    Scott, R. C.
    LANCET NEUROLOGY, 2008, 7 (09): : 771 - 771
  • [39] Evaluation of Romiplostim In a Randomized Placebo-Controlled Phase 3 Study of a Japanese Population with Chronic Immune Thrombocytopenia (ITP)
    Miyazaki, Koji
    Shirasugi, Yukari
    Ando, Kiyoshi
    Tomiyama, Yoshiaki
    Okamoto, Shinichiro
    Kurokawa, Mineo
    Kirito, Keita
    Yonemura, Yuji
    Mori, Shinichiro
    Usuki, Kensuke
    Iwato, Koji
    Hashino, Satoshi
    Wei, Helen
    Lizambri, Richard
    BLOOD, 2010, 116 (21) : 1520 - 1521
  • [40] ELTROMBOPAG IN COMBINATION WITH AZACITIDINE FOR FIRST-LINE TREATMENT OF MDS PATIENTS WITH THROMBOCYTOPENIA: THE RANDOMIZED, PLACEBO-CONTROLLED, PHASE III, SUPPORT STUDY
    Dickinson, M.
    Cherif, H.
    Fenaux, P.
    Mittelman, M.
    Verma, A.
    Portella, M. S. O.
    Burgess, P.
    Platzbecker, U.
    LEUKEMIA RESEARCH, 2017, 55 : S23 - S24
12345